Skip to main content

BIOV · BioVaxys Technology Corp. · Financials

0.0700 CAD +0.0100 (+16.67%) At close · May 5 Intraday price with Plus

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Net Income
-3.95M +48.6%
FY2024 Net Income FY2023–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2024 FY2023
CAD -3.95M -7.69M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.